BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 2 filers reported holding BIOSCRIP INC in Q2 2012. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2013 | $3,000 | -80.0% | 295 | -75.5% | 0.00% | – |
| Q1 2013 | $15,000 | +15.4% | 1,206 | 0.0% | 0.00% | – |
| Q4 2012 | $13,000 | +18.2% | 1,206 | 0.0% | 0.00% | – |
| Q3 2012 | $11,000 | +22.2% | 1,206 | -0.1% | 0.00% | – |
| Q2 2012 | $9,000 | +12.5% | 1,207 | 0.0% | 0.00% | – |
| Q1 2012 | $8,000 | +14.3% | 1,207 | 0.0% | 0.00% | – |
| Q4 2011 | $7,000 | -56.2% | 1,207 | -52.4% | 0.00% | -100.0% |
| Q3 2011 | $16,000 | 0.0% | 2,534 | 0.0% | 0.00% | 0.0% |
| Q2 2011 | $16,000 | -20.0% | 2,534 | -42.0% | 0.00% | 0.0% |
| Q1 2011 | $20,000 | -62.3% | 4,367 | -57.0% | 0.00% | -50.0% |
| Q4 2010 | $53,000 | +39.5% | 10,155 | +37.2% | 0.00% | 0.0% |
| Q3 2010 | $38,000 | +1800.0% | 7,400 | +2070.1% | 0.00% | – |
| Q2 2010 | $2,000 | 0.0% | 341 | +28.7% | 0.00% | – |
| Q1 2010 | $2,000 | 0.0% | 265 | 0.0% | 0.00% | – |
| Q4 2009 | $2,000 | – | 265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVULET CAPITAL, LLC | 1,400,000 | $11,676,000 | 9.66% |
| DSC Advisors, L.P. | 3,150,000 | $26,272,000 | 7.40% |
| Consonance Capital Management LP | 3,950,839 | $32,950,000 | 4.90% |
| NFC Investments, LLC | 951,580 | $7,936,000 | 3.88% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 2,090,789 | $17,437,000 | 3.07% |
| KEANE CAPITAL MANAGEMENT INC | 310,000 | $2,585,000 | 2.41% |
| First Washington CORP | 454,200 | $3,788,000 | 2.12% |
| GLENHILL ADVISORS LLC | 2,486,490 | $20,737,000 | 1.68% |
| ARDSLEY ADVISORY PARTNERS LP | 1,500,000 | $12,510,000 | 1.60% |
| True Bearing Asset Management LP | 357,161 | $2,979,000 | 1.55% |